Aastrom's bone repair product shows promise in trial profiles
This article was originally published in Clinica
Executive Summary
A feasibility clinical trial assessing Aastrom Biosciences' Tissue Repair Cells (TRCs) as a treatment for severe long bone non-union fractures has produced positive results, the Ann Arbor, Michigan firm has reported.